非癌症状况过度诊断证据的评估:一项使用「公平裁判」框架的元流行病学研究
该元流行病学研究系统检索非癌症状况中过度诊断的研究,采用「公平裁判」框架评估证据强度。132项研究中47项(36%)无公平裁判,仅21%使用疾病特异性临床结局裁判。过度诊断估计包括筛查发现的腹主动脉瘤43-45%、急性肾损伤54%、妊娠羊水过少77%。结论认为当前非癌症状况过度诊断证据大多薄弱。
要点
- 132项研究中47项(36%)无公平裁判,仅21%使用疾病特异性临床结局裁判。
- 过度诊断估计:筛查发现的腹主动脉瘤43-45%,急性肾损伤54%,妊娠羊水过少77%。
- 当前非癌症状况过度诊断证据大多薄弱,框架可指导稳健研究设计。
核心结论
- 当前非癌症状况过度诊断证据大多薄弱。
- 应用该框架可指导设计稳健研究以检测和估计非癌症状况的过度诊断,最终为减少过度诊断的循证政策提供信息。
研究设计与样本
- 系统检索研究非癌症状况过度诊断的研究。
- 使用「公平裁判」框架评估证据,两名评价者独立判定是否存在公平裁判(疾病特异性临床结局、检测结果或风险因素)。
- 共纳入132项研究。
主要发现
- 132项研究中47项(36%)无公平裁判以裁定额外诊断。
- 有公平裁判时,最常见为单一检测或风险因素(32%的研究),疾病特异性临床结局裁判仅占21%的研究。
- 过度诊断估计包括筛查发现的急性腹部动脉瘤43-45%、急性肾损伤54%、妊娠羊水过少77%。
关键数值与推荐
- 疾病特异性临床结局提供最强过度诊断证据,随访或同期检测提供较弱证据,风险因素仅提供弱证据。
- 无公平裁判的研究提供最弱的过度诊断证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the strength of the evidence for, and the extent of, overdiagnosis in noncancer conditions. STUDY DESIGN AND SETTING: We systematically searched for studies investigating overdiagnosis in noncancer conditions. Using the 'Fair Umpire' framework to assess the evidence that cases diagnosed by one diagnostic strategy but not by another may be overdiagnosed, two reviewers independently identified whether a Fair Umpire-a disease-specific clinical outcome, a test result or risk factor that can determine whether an additional case does or does not have disease-was present. Disease-specific clinical outcomes provide the strongest evidence for overdiagnosis, follow-up or concurrent tests provide weaker evidence, and risk factors provide only weak evidence. Studies without a Fair Umpire provide the weakest evidence of overdiagnosis. RESULTS: Of 132 studies, 47 (36%) did not include a Fair Umpire to adjudicate additional diagnoses. When present, the most common Umpire was a single test or risk factor (32% of studies), with disease-specific clinical outcome Umpires used in only 21% of studies. Estimates of overdiagnosis included 43-45% of screen-detected acute abdominal aneurysms, 54% of cases of acute kidney injury, and 77% of cases of oligohydramnios in pregnancy. CONCLUSION: Much of the current evidence for overdiagnosis in noncancer conditions is weak. Application of the framework can guide development of robust studies to detect and estimate overdiagnosis in noncancer conditions, ultimately informing evidence-based policies to reduce it.
引用
- Sanders S, Barratt A, Buchbinder R, et al. Evidence for overdiagnosis in noncancer conditions was assessed: a metaepidemiological study using the 'Fair Umpire' framework. J Clin Epidemiol. 2023. PMID: 37952702. doi:10.1016/j.jclinepi.2023.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。